Fox Run Management L.L.C. Raises Stake in LivaNova PLC $LIVN

Key Points

• Fox Run Management L.L.C. increased its stake in LivaNova PLC by 35.3%, acquiring 6,995 shares valued at approximately $1,054,000.
• LivaNova reported earnings of $1.05 per share, surpassing analysts' expectations, with a year-over-year revenue growth of 10.6% to $352.50 million.
• Stocks of LivaNova have been positively rated by various analysts, with a consensus rating of "Buy" and an average target price of $59.29.

Fox Run Management L.L.C. grew its stake in LivaNova PLC (NASDAQ:LIVN - Free Report) by 35.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 26,838 shares of the company's stock after purchasing an additional 6,995 shares during the period. Fox Run Management L.L.C.'s holdings in LivaNova were worth $1,054,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. UMB Bank n.a. boosted its stake in shares of LivaNova by 340.5% in the 1st quarter. UMB Bank n.a. now owns 837 shares of the company's stock valued at $33,000 after purchasing an additional 647 shares in the last quarter. CWM LLC boosted its position in LivaNova by 52.3% during the 1st quarter. CWM LLC now owns 871 shares of the company's stock worth $34,000 after buying an additional 299 shares during the period. Caitong International Asset Management Co. Ltd boosted its position in LivaNova by 415.4% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,469 shares of the company's stock worth $58,000 after buying an additional 1,184 shares during the period. Russell Investments Group Ltd. boosted its position in LivaNova by 17.1% during the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock worth $70,000 after buying an additional 219 shares during the period. Finally, Sterling Capital Management LLC boosted its position in LivaNova by 800.6% during the 4th quarter. Sterling Capital Management LLC now owns 1,621 shares of the company's stock worth $75,000 after buying an additional 1,441 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

LivaNova Trading Down 0.8%

Shares of NASDAQ:LIVN traded down $0.45 during mid-day trading on Monday, hitting $53.27. The company had a trading volume of 474,827 shares, compared to its average volume of 711,179. The firm has a fifty day moving average price of $45.84 and a 200 day moving average price of $42.84. The company has a market capitalization of $2.91 billion, a PE ratio of -13.69 and a beta of 0.92. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.29 and a quick ratio of 1.09. LivaNova PLC has a one year low of $32.48 and a one year high of $57.35.

LivaNova (NASDAQ:LIVN - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $1.05 EPS for the quarter, beating analysts' consensus estimates of $0.84 by $0.21. The business had revenue of $352.50 million during the quarter, compared to analyst estimates of $332.20 million. LivaNova had a negative net margin of 16.13% and a positive return on equity of 14.57%. LivaNova's quarterly revenue was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.93 EPS. As a group, research analysts forecast that LivaNova PLC will post 2.85 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Wall Street Zen upgraded shares of LivaNova from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. Robert W. Baird lifted their target price on shares of LivaNova from $55.00 to $61.00 and gave the stock an "outperform" rating in a research report on Thursday, May 8th. Wolfe Research upgraded shares of LivaNova from a "peer perform" rating to an "outperform" rating and set a $60.00 target price on the stock in a research report on Tuesday, May 20th. Needham & Company LLC reiterated a "buy" rating and set a $64.00 target price on shares of LivaNova in a research report on Tuesday, May 13th. Finally, Barclays lowered their price target on shares of LivaNova from $56.00 to $55.00 and set an "equal weight" rating for the company in a report on Thursday, May 8th. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $59.29.

LivaNova Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.